BACKGROUND: Brugada syndrome is associated with a risk for sudden death, but the arrhythmic risk in an individual Brugada syndrome patient is difficult to predict. Pathologic changes in the early repolarization phase of the ventricular action potential probably constitute part of the arrhythmogenic substrate in Brugada syndrome. Microvolt T wave alternans (TWA) assesses dynamic beat-to-beat changes in repolarization and has been suggested as a marker for repolarization-related sudden death. We therefore tested whether TWA is an indicator for arrhythmias in Brugada syndrome with a focus on right precordial ECG leads. METHODS: We assessed TWA in nine symptomatic, inducible patients with established Brugada syndrome and in seven healthy controls. TWA was assessed at rest and during exercise using both standard methods and an algorithm that assesses TWA in the early ST segment and the right precordial leads. RESULTS: None of the Brugada patients developed TWA in this study irrespective of analysis at rest or during exercise, neither using standard methods nor when the early ST segment was included in the analysis. When the early ST segment was included in the analysis, nonsustained TWA was found in three out of seven, and sustained TWA in one control. CONCLUSION: T wave alternans is not an appropriate test to detect arrhythmic risk in patients with Brugada syndrome.
BACKGROUND:Brugada syndrome is associated with a risk for sudden death, but the arrhythmic risk in an individual Brugada syndromepatient is difficult to predict. Pathologic changes in the early repolarization phase of the ventricular action potential probably constitute part of the arrhythmogenic substrate in Brugada syndrome. Microvolt T wave alternans (TWA) assesses dynamic beat-to-beat changes in repolarization and has been suggested as a marker for repolarization-related sudden death. We therefore tested whether TWA is an indicator for arrhythmias in Brugada syndrome with a focus on right precordial ECG leads. METHODS: We assessed TWA in nine symptomatic, inducible patients with established Brugada syndrome and in seven healthy controls. TWA was assessed at rest and during exercise using both standard methods and an algorithm that assesses TWA in the early ST segment and the right precordial leads. RESULTS: None of the Brugada patients developed TWA in this study irrespective of analysis at rest or during exercise, neither using standard methods nor when the early ST segment was included in the analysis. When the early ST segment was included in the analysis, nonsustained TWA was found in three out of seven, and sustained TWA in one control. CONCLUSION: T wave alternans is not an appropriate test to detect arrhythmic risk in patients with Brugada syndrome.
Authors: C Bezzina; M W Veldkamp; M P van Den Berg; A V Postma; M B Rook; J W Viersma; I M van Langen; G Tan-Sindhunata; M T Bink-Boelkens; A H van Der Hout; M M Mannens; A A Wilde Journal: Circ Res Date: 1999 Dec 3-17 Impact factor: 17.367
Authors: L Eckardt; P Kirchhof; P Loh; E Schulze-Bahr; R Johna; T Wichter; G Breithardt; W Haverkamp; M Borggrefe Journal: J Cardiovasc Electrophysiol Date: 2001-06
Authors: M B Rook; C Bezzina Alshinawi; W A Groenewegen; I C van Gelder; A C van Ginneken; H J Jongsma; M M Mannens; A A Wilde Journal: Cardiovasc Res Date: 1999-12 Impact factor: 10.787
Authors: T Ikeda; H Sakurada; K Sakabe; T Sakata; M Takami; N Tezuka; T Nakae; M Noro; Y Enjoji; T Tejima; K Sugi; T Yamaguchi Journal: J Am Coll Cardiol Date: 2001-05 Impact factor: 24.094
Authors: L Eckardt; P Kirchhof; E Schulze-Bahr; S Rolf; M Ribbing; P Loh; H-J Bruns; A Witte; P Milberg; M Borggrefe; G Breithardt; T Wichter; W Haverkamp Journal: Eur Heart J Date: 2002-09 Impact factor: 29.983
Authors: Richard L Verrier; Thomas Klingenheben; Marek Malik; Nabil El-Sherif; Derek V Exner; Stefan H Hohnloser; Takanori Ikeda; Juan Pablo Martínez; Sanjiv M Narayan; Tuomo Nieminen; David S Rosenbaum Journal: J Am Coll Cardiol Date: 2011-09-20 Impact factor: 24.094
Authors: Jörn Schmitt; Stefan Baumann; Thomas Klingenheben; Sergio Richter; Gabor Duray; Stefan H Hohnloser; Joachim R Ehrlich Journal: Ann Noninvasive Electrocardiol Date: 2009-10 Impact factor: 1.468